Fred Apple – Access Immunoassay DXI 9000 Platform Comparison, Beckman Coulter

Fred Apple – FT3 and T4 Roche Testing, Beckman Coulter

Fred Apple –Roche Elecsys e411 Progesterone III assay, Bechman Coulter

Fred Apple – T4 on Four Platforms, Bechman Coulter

Jason Baker – An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin  for the Treatment of Adult Outpatients in Early Stages of COVID-19, a.k.a. Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC), INSIGHT Protocol Number: 012, University of Minnesota

Jason Baker – PrEP IT: A Pilot Test of a Mobile Peer Support Intervention to Optimize PrEP Adherence and Retention in PrEP Care for Youth, National Institutes of Health; National Institute of Mental Health; San Diego State University

Jason Baker – A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized patients with COVID-19, National Institutes of Health; INSIGHT; Institute for Clinical Research, Inc.

Jason Baker – An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19, National Institutes of Health; INSIGHT; Institute for Clinical Research, Inc.

Jason Baker – Investigation of Persistent HIV Immune Stimulation in Lymphoid Tissues During Therapy as a Cause of Sustained Immune Activation, National Institutes of Health; National Institute of Allergy and Infectious Diseases; University of Minnesota

Jason Baker – A Multicenter Platform Evaluating Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults, National Institutes of Health; National Institutes of Allergy and Infectious Diseases; Division of Microbiology Infectious Diseases; Social & Scientific Systems, Inc.

Gavin Bart – North Star Node of the Clinical Trials Network: Engaging African American Faith-Based Leaders in a Substance Use, National Institutes of Health; National Institute on Drug Abuse

Andrew Busch – Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) Project 2: A Pragmatic Trial of Chronic Disease Approaches To Ameliorate Tobacco Related Cardiovascular Disease Health Disparities-TRAINING CORE COMPANION, National Institutes of Health; University of Minnesota

David Darrow – A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MT-3921 in Subjects with Acute Traumatic Cervical Spinal Cord Injury, Mitsubishi Tanabe Pharma Development America, Inc.

Allyson Hart – UMN CTSI Mothers Leading Science, University of Minnesota

William Henry – A Phase 2 Randomized, Open-Label, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of Islatravir in Combination with Lenacapavir in Virologically Suppressed People with HIV, Gilead Sciences, Inc.

Sara Hylwa-Deufel, Michelle Xiong – Analysis of Formeldehyde Content in Eyelash Extension Glue, American Contact Dermatitis Society

Nicole Jacobi – The Effect of Hyperinsulinemia on CAC Scores of Cancer Survivors, Randy Shaver Cancer Research & Community Fund

Sandra Japuntich – Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) Project 2: A Pragmatic Trial of Chronic Disease Approaches To Ameliorate Tobacco Related Cardiovascular Disease Health Disparities-ADMINISTRATIVE CORE COMPANION, National Institutes of Health; University of Minnesota

Sandra Japuntich – Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) Project 2: A Pragmatic Trial of Chronic Disease Approaches To Ameliorate Tobacco Related Cardiovascular Disease Health Disparities-PROJECT 2 COMPANION, National Institutes of Health; University of Minnesota

Marc Martel – A Hospital-Based Retrospective Chart Review to Assess the Management of Acute Agitation in Adult Patients with Schizophrenia and Bipolar Disorder Presenting to the Emergency Department (ED) in the US, Actu-Real, Inc.

Warren McKinney – Minnesota Learning Health System Mentored Career Development Program (MNLHS), Agency for Healthcare Research and Quality; University of Minnesota

Rick Odland – Monitoring Free Flaps with Pulse Pressure, Lions Hearing Foundation; University of Minnesota

John Sethells – An Evaluation of Beta-Nicotyrine as a Potential Contributor to the Abuse Liability of e-Cigarettes, National Institutes of Health; National Institute on Drug Abuse

Stephen Smith – Training and Test a Machine-Learning Artificial Neural Network (ANN) to Diagnose Electorcardiographic (ECG) Abnormalities, PulseAI

Katherine Vickery – Center Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) Project 2: A Pragmatic Trial of Chronic Disease Approaches To Ameliorate Tobacco Related Cardiovascular Disease Health Disparities-COMMUNITY ENGAGEMENT CORE, National Institutes of Health; University of Minnesota

Tyler Winkelman – Health, Homlessness, and Criminal Justice Lab - COVID 19 Vaccine Project, Minnesota Department of Health